| Keryx Completes Phase 3 Enrollment for Zerenex - Renal Business Today |
|
|
Renal Business Today... phosphate binder for the treatment of elevated serum phosphorous levels, or hyperphosphatemia, in patients with end-stage renal disease on dialysis. ...Keryx Pharmaceuticals Rallies but Remains Undervalued Seeking AlphaKeryx Biopharmaceuticals to Present at Oppenheimer's 21st Annual Healthcare ... read more |